Wuhan Hvsen Biotechnology Co Ltd (300871) — Cash Flow Quality Index
Wuhan Hvsen Biotechnology Co Ltd (300871) has a Cash Flow Quality Index of 0.84x as of September 2025. Operating cash flow of CN¥59.06 Million is below net income of CN¥70.72 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Wuhan Hvsen Biotechnology Co Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wuhan Hvsen Biotechnology Co Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Wuhan Hvsen Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300871 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Wuhan Hvsen Biotechnology Co Ltd (2016–2025)
Year-by-year earnings quality comparison for Wuhan Hvsen Biotechnology Co Ltd. For live market cap and the full company financial profile, see 300871 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥238.45 Million | CN¥253.16 Million | ▼ -83.0% |
| 2023 | 5.54x | CN¥92.92 Million | CN¥16.78 Million | ▲ +201.9% |
| 2022 | 1.83x | CN¥96.68 Million | CN¥52.71 Million | ▲ +56.5% |
| 2021 | 1.17x | CN¥155.72 Million | CN¥132.87 Million | ▲ +264.0% |
| 2020 | 0.32x | CN¥48.35 Million | CN¥150.16 Million | ▼ -79.0% |
| 2019 | 1.53x | CN¥105.24 Million | CN¥68.77 Million | ▲ +418.0% |
| 2018 | 0.30x | CN¥21.10 Million | CN¥71.40 Million | ▼ -67.6% |
| 2017 | 0.91x | CN¥80.56 Million | CN¥88.41 Million | ▼ -25.0% |
| 2016 | 1.21x | CN¥60.00 Million | CN¥49.40 Million | — |